Postdoc: Cancer Epigenetics & Immune Interactions

Jefferson Health; United States; On-site; USD 55,000 - 75,000; Full time

Benefits offered by this job

Medical Insurance

Dental Coverage

Vision Insurance

Retirement Plans

Tuition Assistance

Job summary

The laboratory of Dr. Jianping Li at Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, seeks a highly motivated postdoctoral fellow to work on NIH/NCI-funded projects investigating chromatin regulators and immune interactions in blood cancers.

The candidate should have a recent PhD/PhD-MD in molecular biology or related fields and a strong interest in cancer epigenetics and translational research.

Qualifications

• PhD or PhD/MD in molecular biology, T-cell immunology, cancer biology, or related fields.
• Strong interest in chromatin regulation, cancer epigenetics, stem cell biology, immune interactions, or CNS infiltration.
• Experience in molecular cloning, CRISPR editing and screening, multi-omics sequencing analysis, flow cytometry and sorting preferred.

Responsibilities

• Perform in-depth molecular and cellular experiments to study chromatin regulators and immune interactions in blood cancers.
• Collaborate with interdisciplinary teams on NIH/NCI-funded projects and contribute to data analysis and interpretation.
• Assist in manuscript preparation and dissemination of findings; participate in career development toward independent research.

Skills

Molecular biology

CRISPR editing

Flow cytometry

Multi-omics analysis

Cell culture

Education

PhD in molecular biology or related field

Tools

CUT&RUN

ChIP-Seq

single-cell RNA-Seq

ATAC-Seq

Hi-C

Job description

The laboratory of Dr. Jianping Li at Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, seeks a highly motivated postdoctoral fellow to work on NIH/NCI-funded projects investigating chromatin regulators and immune interactions in blood cancers.

The candidate should have a recent PhD/PhD-MD in molecular biology or related fields and a strong interest in cancer epigenetics and translational research.